克拉屈滨——多发性硬化症脉冲免疫重建的新老选择。
Cladribine - an old newcomer for pulsed immune reconstitution in MS.
机构信息
Department of Neurology, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149 Münster, Germany.
出版信息
Nat Rev Neurol. 2017 Oct;13(10):573-574. doi: 10.1038/nrneurol.2017.119. Epub 2017 Sep 8.
PMID:28884753
Abstract
The EMA has approved cladribine tablets for the treatment of multiple sclerosis. The drug is not new, and the journey to its approval has been a long one, but the old concepts that cladribine therapy are based on provide a new option for the possibility of drug-free remission.
摘要
EMA 批准克拉屈滨片用于治疗多发性硬化症。该药物并不新鲜，其获批之路也颇为漫长，但基于克拉屈滨疗法的旧观念为无药物缓解的可能性提供了新选择。
Zotero 插件